---
layout: firm_page
title: "UCB Ventures"
id: "ucbventures.com"
permalink: "/ucbventuresucbventures.com/"
website: "https://www.ucbventures.com"
offices: "Brussels (Belgium), London (United Kingdom), Boston (United States)"
investment_stages: "Seed, Series A, Series B"
portfolio_companies: "Switch Therapeutics, Code Bio, SpliceBio, EsoBiotec, Neurona, Walden Biosciences, Rinri Therapeutics, ExeVir Bio, ViaNautis, Iris Medicine, Seamless, Syndesi Therapeutics, Ally Therapeutics, StrideBio, Locana"
portfolio_link: "https://www.ucbventures.com/portfolio"
investment_markets: "Next-generation cell and gene therapy, regenerative medicine, cell and tissue homeostasis, RNA modulation, Oligo-based and synthetic biology therapeutics"
founded_year: "2017"
description: "UCB Ventures is an evergreen strategic corporate venture fund established in 2017. It makes long-term investments in early-stage companies developing novel therapeutic modalities and platforms in areas adjacent to UCB's therapeutic focus. The firm works closely with entrepreneurs to maximize patient value."
linkedin: "https://www.linkedin.com/company/ucb-ventures"
twitter: "https://www.twitter.com/ucb_news"
instagram: ""
team_page: "https://www.ucbventures.com/team"
investor_type: "Corporate VC"
crunchbase: "https://www.crunchbase.com/organization/ucb-ventures"
pitchbook: ""

# SEO Optimization
meta_title: "UCB Ventures - VC Firm - projectstartups.com"
meta_description: "UCB Ventures, UCB Ventures is an evergreen strategic corporate venture fund established in 2017. It makes long-term investments in early-stage companies developing ..."
meta_keywords: "UCB Ventures, Next-generation cell and gene therapy, regenerative medicine, cell and tissue homeostasis, RNA modulation, Oligo-based and synthetic biology therapeutics, VC firm, venture capital, startup investor, projectstartups.com"
canonical_url: "https://vc.projectstartups.com/ucbventuresucbventures.com/"
---